DALLAS, March 18, 2014 /PRNewswire/ --
The Diabetes App Market Report 2014, available with ReportsnReports.com, is a comprehensive analysis about the performance of diabetes apps, key players, best practices, country markets, regulatory impact, market trends and revenues from 2008-2018. The report is based on a detailed data set of 1100 diabetes apps available for the iOS and Android operating system in 27 countries.
More than 30 interviews with physicians, diabetics, app developers and publishers have been conducted to discuss the current status of the market as well as future trends. In addition, more than 20 mHealth app communities have been investigated to include feedback from diabetes app users. The most representative feedback from the interviews and community investigation are included in the report. Complete Diabetes App Market Report 2014 is available at http://www.reportsnreports.com/reports/276919-diabetes-app-market-report-2014.html .
Diabetes has become a global epidemic with significant impact on society and the economy. In 2013 around 382M people around the world were estimated to suffer from diabetes. Mobile applications promise to play an invaluable role in assisting people who suffer from diabetes to empower them to better manage their condition and as a consequence reduce health care costs. Mobile apps can aid in the daily management of diabetes by supporting behaviour changes, facilitating communication and easing the hassle of keeping track of all relevant parameters that have an influence on the disease.
Currently there are more than 1100 iOS and Android apps listed on the Apple App Store and Google Play that are specifically designed for diabetics and healthcare professionals to treat diabetics.
The report examines in detail the initial years of the app market (2008-2013) and provides an outlook of the next phase (2014-2018).
The report includes:
- Analysis and categorization of 1100 diabetes apps
- Description of 6 best practice elements that constitutes a successful diabetes app
- Detailed market analysis of the last 5 years (2008-2013) including size of the addressable market, downloads, business model and platform market share, app and in-app-purchase price development, market revenue total and by revenue sources
- Profiles of top 14 diabetes app publishers that represent 65% of market share including diabetes app portfolio description and its performance
- Top 10 country profiles that represent the biggest local markets for diabetes apps including cumulated market downloads and active users per platform
- Analysis of available clinical trials that investigate the impact of mobile apps on the diabetes care
- Interpretation of regulatory guidelines from the FDA on diabetes apps
- Description of the main factors that will influence the diabetes app market in the next five years
- Detailed market forecast including downloads, revenues, user penetration in target group, app related sensor shipment and service user numbers
Leading diabetes app players, apps and market share discussed in Diabetes App Market Report 2014 include Azumio Inc., Sanofi-Aventis, Medivo, Distal Thoughts, BHI Technologies Inc., Maxwell Software, Tactio Health Group Inc., Everyday Health Inc., Taconic System LLC¸ AgaMatrix, mySugr, Medisana AG, Medtronic Inc. and Telcare Inc. Order a copy of this research report at http://www.reportsnreports.com/Purchase.aspx?name=276919 . Choose the company/corporate license to also receive a PowerPoint package of all charts used in the report.
The report answers questions like:
- What is the addressable market of diabetes apps globally and in major countries?
- What constitutes a best practise diabetes app?
- Under which circumstances does a diabetes app have to get pre-market approval by the regulatory organizations?
- What are the main competitors and how do they perform?
- What size has the addressable market in one of the major countries?
- What are the main sources of revenue for diabetes app publishers today and in five years?
Other diabetes market research reports available with us include:
Published in Jan 2014, the Trends and Opportunities in the Diabetes Care Market (http://www.reportsnreports.com/reports/273309-trends-and-opportunities-in-the-diabetes-care-market.html ) research report provides a complete and comprehensive review of the current diabetes device market, highlighting and analysing the market leaders, competing products and new developments across a wide range of technology areas. Furthermore, this report also acts as a diabetes device manufacturer directory detailing each company's recent key events in the diabetes sector and providing granular financial data (where available). It also covers information on market dynamics, detailed breakdown of key leading products, competing products and products in development for Diabetes Monitoring Products and Insulin Delivery Products; current products and products in development within Combined CGM-Insulin Pump Systems technologies; current research and development for Artificial Pancreas Technologies as well as diabetes device company directory and company profiles for market-leading companies, detailing recent key events and important financial data.
PharmaPoint: Microvascular Complications of Diabetes - Current and Future Players (http://www.reportsnreports.com/reports/274608-pharmapoint-microvascular-complications-of-diabetes-current-and-future-players.html ) research report identifies and analyses the key companies shaping and driving the global Microvascular Complications of Diabetes market. The report provides insight into the competitive Microvascular Complications of Diabetes landscape, including new companies entering the market. Companies profiled in this report include Roche, Novartis, Regeneron, Bayer, Eli Lilly, Pfizer and AbbVie.
Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019 (http://www.reportsnreports.com/reports/268735-type-2-diabetes-market-to-2019-a-shifting-treatment-algorithm-and-intensified-competition-expected-to-drive-growth-by-2019.html ) research report says there is currently a large number of blood glucose-lowering drugs in the crowded type 2 diabetes market indicated for the treatment of chronically high blood glucose. The market is led by Lantus, which achieved global sales amounting to $6.4 billion in 2012. Over the forecast period from 2012 to 2019, the safer, more efficacious newer classes of drug (GLP-1 agonists, DPP-4 Inhibitors and SGLT-2 inhibitors) are expected to capture substantial market shares, largely replacing older classes such as sulfonylureas and thiazolidinediones. Additionally, a variety of novel drugs belonging to these newer classes are due to enter the market, and are expected to offer a moderate improvement in terms of efficacy and safety. The price of these new therapies is expected to be high, but this is unlikely to hinder their uptake. As a result, as well as an overall increase in the prevalent population, this report believes that the value of the global market has the potential to grow to reach $38.8 billion by 2019.
Table of Contents for Diabetes App Market Report 2014 include:
2 Scope of the report 5
3 Management summary 6
4 The need for innovative mobile apps supporting diabetes patients 8
4.1 The global diabetes epidemics 10
4.2 The explosion of diabetes treatment costs 11
5 The promises of mobile apps for diabetes care 13
5.1 The impact of diabetes apps on daily diabetes management 13
5.2 The clinical trial results: The proof that diabetes apps hold their promises 14
5.3 The addressable target group size for diabetes apps in 2013 18
6 Categorization of diabetes apps 19
6.1 The 4 most common diabetes app categories 21
6.2 What makes a best practice diabetes app? 24
7 Regulation for diabetes apps 30
8 Current status of the diabetes app market 35
8.1 Number of diabetes apps and publishers 36
8.2 Diabetes app downloads and active users 39
8.3 Diabetes apps pricing 46
8.4 Diabetes apps market revenues 2008-2013 47
9 Diabetes app market country statistics 51
9.1 The US diabetes app market country statistics 54
9.2 The UK diabetes app market country statistics 55
9.3 The German diabetes app market country statistics 56
9.4 The Canadian diabetes app market country statistics 57
9.5 The French diabetes app market country statistics 58
9.6 The Spanish diabetes app market country statistics 59
9.7 The Australian diabetes app market country statistics 60
9.8 The Italian diabetes app market country statistics 61
9.9 The Chinese diabetes app market country statistics 62
9.10 The Japanese diabetes app market country statistics 63
10 Leading diabetes app players, apps and market share 64
10.1 Profile 1: Azumio Inc. 64
10.1.1 Diabetes app profile 64
10.1.2 Leading app: Glucose Buddy 65
10.1.3 Leading app: Blood Sugar Tracker by healthycloud.com 65
10.2 Profile 2: sanofi-aventis 66
10.2.1 Diabetes app profile 66
10.2.2 Leading app: GoMeals 66
10.2.3 Leading app: iBGStar 67
10.3 Profile 3: Medivo 68
10.3.1 Diabetes app profile 68
10.3.2 Leading app: OnTrack Diabetes 68
10.4 Profile 4: Distal Thoughts 68
10.4.1 Diabetes app profile 69
10.4.2 Leading app: Diabetes Log 69
10.5 Profile 5: BHI Technologies Inc. 69
10.5.1 Diabetes app profile 69
10.5.2 Leading app: Diabetes App 70
10.6 Profile 6: Maxwell Software 70
10.6.1 Diabetes app profile 70
10.6.2 Leading app: Glucose Companion for iPad 71
10.6.3 Leading app: Daily Carb - Carbohydrate, Glucose, Medication, Blood Pressure and Exercise Tracker 72
10.7 Profile 7: Tactio Health Group Inc. 72
10.7.1 Diabetes app profile 72
10.7.2 Leading app: TactioHealth 73
10.8 Profile 8: Everyday Health Inc. 73
10.8.1 Diabetes app profile 74
10.8.2 Leading app: Diabetes in Check 74
10.9 Profile 9: Taconic System LLC 74
10.9.1 Diabetes app profile 74
10.9.2 Leading app: Healthsome G for Glucose by Taconic System LLC 75
10.10 Profile 10: AgaMatrix 75
10.10.1 Diabetes app profile 75
10.10.2 Main app: WaveSense Diabetes Manager 76
10.11 Profile 11: mySugr 76
10.11.1 Diabetes app profile 76
10.11.2 Leading app: Diabetes Companion by mySugr 77
10.12 Profile 12: Medisana AG 77
10.12.1 Diabetes app profile 78
10.12.2 Leading app: VitaDock 78
10.13 Profile 13: Medtronic Inc. 78
10.13.1 Diabetes app profile 79
10.13.2 Leading app: Carb Counting with Lenny 79
10.14 Profile 14: Telcare Inc. 79
10.14.1 Diabetes app profile 80
10.14.2 Leading app: Diabetes Pal App 80
11 Outlook: The next five years until 2018 81
11.1 Addressable market size, active user and download number forecast (2014-2018) 82
11.2 Market revenue, device shipment and service user development forecast 2014 - 2018 87
12 Appendix 92
12.1 About research2guidance 92
12.2 List of diabetes apps 93
12.3 List of tables and figures 112
Explore more reports on the healthcare market at http://www.reportsnreports.com/market-research/healthcare/ .
ReportsnReports.com is an online market research reports library of 400,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Connect With Us on: